Send us a text In this episode of The Psychedelic Psychiatrist, we dive deep into the various routes of administering ketamine in Ketamine-Assisted Psychotherapy (KAP), from IV infusions to sublingual lozenges. We explore how each route impacts the therapeutic process, differences in bioavailability, and how the choice of administration affects both the experience and outcome. Come visit our website for more information: Innerbloom
All content for The Psychedelic Psychiatrist is the property of The Psychedelic Psychiatrist and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text In this episode of The Psychedelic Psychiatrist, we dive deep into the various routes of administering ketamine in Ketamine-Assisted Psychotherapy (KAP), from IV infusions to sublingual lozenges. We explore how each route impacts the therapeutic process, differences in bioavailability, and how the choice of administration affects both the experience and outcome. Come visit our website for more information: Innerbloom
The Darker Side of Psychedelics: Response to NY Magazine's Cover Story podcast (Part 4)
The Psychedelic Psychiatrist
17 minutes
3 years ago
The Darker Side of Psychedelics: Response to NY Magazine's Cover Story podcast (Part 4)
Send us a text Part 4 of our conversation continued... For those of you who don’t know, New York Magazine's Cover Story published a podcast series called 'Power Trip’ looking into the dark side of psychedelic therapy. The podcast highlights various traumatic experiences that have occurred under the umbrella of psychedelic therapy. One woman tells of the abuse she experienced by her therapist during the MAPS MDMA trials for PTSD. The Cover Story podcast additionally went on ...
The Psychedelic Psychiatrist
Send us a text In this episode of The Psychedelic Psychiatrist, we dive deep into the various routes of administering ketamine in Ketamine-Assisted Psychotherapy (KAP), from IV infusions to sublingual lozenges. We explore how each route impacts the therapeutic process, differences in bioavailability, and how the choice of administration affects both the experience and outcome. Come visit our website for more information: Innerbloom
